Provided by Tiger Trade Technology Pte. Ltd.

Cytek BioSciences

5.81
-0.0050-0.09%
Volume:443.58K
Turnover:2.57M
Market Cap:754.55M
PE:-9.21
High:5.94
Open:5.86
Low:5.75
Close:5.81
52wk High:6.18
52wk Low:3.31
Shares:129.98M
Float Shares:103.00M
Volume Ratio:0.54
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6300
EPS(LYR):-0.5209
ROE:-23.04%
ROA:-6.31%
PB:2.34
PE(LYR):-11.14

Loading ...

Mar 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 20, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 02, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans